Organogenesis Holdings Inc.

Nasdaq:ORGO

Pharmaceutical Preparations·CANTON, MA

Organogenesis is the phase of embryonic development that starts at the end of gastrulation and continues until birth. During organogenesis, the three germ layers formed from gastrulation form the tissues and internal organs of the organism.

CEO

Gillheeney Gary S.

CFO

Francisco David

Financials

20 shown

Type	Period	Ended	Filed
10-K	FY 2025	12/31/25	2/26/26	→
10-Q	Q3 2025	9/30/25	11/6/25	→
10-Q	Q2 2025	6/30/25	8/7/25	→
10-Q	Q1 2025	3/31/25	5/8/25	→
10-K/A	FY 2024	12/31/24	4/29/25	→
10-K	FY 2024	12/31/24	2/27/25	→
↓

Earnings Releases (8-K)

36 shown

Filed	Period
2/26/26	Q1 FY2026	→
11/6/25	Q4 FY2025	→
8/7/25	Q3 FY2025	→
5/8/25	Q2 FY2025	→
2/27/25	Q1 FY2025	→
11/12/24	Q4 FY2024	→
↓

News (8-K)

44 shown

Filed	Type	Description
2/23/26	Exec Change	Departure or Appointment of Directors or Certain Officers	→
12/29/25	Agreement	Entry into a Material Definitive Agreement	→
9/25/25	Reg FD	Regulation FD Disclosure	→
6/24/25	Exec Change	Departure or Appointment of Directors or Certain Officers	→
3/27/25	Reg FD	Regulation FD Disclosure	→
12/2/24	Agreement	Entry into a Material Definitive Agreement	→
↓

Prospectuses & Registrations

40 shown

Filed	Form	Description
8/7/25	S-8	S-8	→
5/12/25	ARS	ARS	→
12/23/24	424B3	424B3	→
12/19/24	S-3	S-3	→
8/8/24	S-3	S-3	→
4/29/24	ARS	ARS	→
↓

Filing History(659 filings)

TypeDateAccessionPeriodSize

Mar 3, 2026

0002064832-26-000093STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP OF SECURITIES

Mar 1, 2026

4.4 KB

4/A

Mar 3, 2026

0002064832-26-000092AMENDED STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP OF SECURITIES

Feb 18, 2026

6.3 KB

4/A

Mar 3, 2026

0002064832-26-000091AMENDED STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP OF SECURITIES

Feb 18, 2026

6.3 KB

4/A

Mar 3, 2026

0002064832-26-000090AMENDED STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP OF SECURITIES

Feb 18, 2026

6.3 KB

4/A

Mar 3, 2026

0002064832-26-000089AMENDED STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP OF SECURITIES

Feb 18, 2026

6.3 KB

4/A

Mar 3, 2026

0002064832-26-000088AMENDED STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP OF SECURITIES

Feb 18, 2026

6.3 KB

4/A

Mar 3, 2026

0002064832-26-000087AMENDED STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP OF SECURITIES

Feb 18, 2026

6.3 KB

4/A

Mar 3, 2026

0002064832-26-000086AMENDED STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP OF SECURITIES

Feb 18, 2026

6.3 KB

Feb 27, 2026

0002064832-26-000065INITIAL STATEMENT OF BENEFICIAL OWNERSHIP OF SECURITIES

Feb 18, 2026

7.5 KB

10-K

Feb 26, 2026

0001193125-26-07673010-K

Dec 31, 2025

17.3 MB

8-K

Feb 26, 2026

0001193125-26-0765958-K

Feb 26, 2026

1.2 MB

8-K

Feb 23, 2026

0001193125-26-0642708-K

Feb 18, 2026

132.5 KB

Feb 20, 2026

0002064832-26-000062STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP OF SECURITIES

Feb 18, 2026

9.9 KB

Feb 20, 2026

0002064832-26-000061STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP OF SECURITIES

Feb 18, 2026

9.9 KB

Feb 20, 2026

0002064832-26-000060STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP OF SECURITIES

Feb 18, 2026

9.9 KB

Feb 20, 2026

0002064832-26-000059STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP OF SECURITIES

Feb 18, 2026

9.9 KB

Feb 20, 2026

0002064832-26-000058STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP OF SECURITIES

Feb 18, 2026

9.9 KB

Feb 20, 2026

0002064832-26-000057STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP OF SECURITIES

Feb 18, 2026

9.9 KB

Feb 20, 2026

0002064832-26-000056STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP OF SECURITIES

Feb 18, 2026

4.7 KB

Feb 20, 2026

0002064832-26-000055STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP OF SECURITIES

Feb 18, 2026

4.7 KB

Feb 20, 2026

0002064832-26-000054STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP OF SECURITIES

Feb 18, 2026

4.7 KB

Feb 20, 2026

0002064832-26-000053STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP OF SECURITIES

Feb 18, 2026

9.9 KB

Feb 20, 2026

0002064832-26-000052STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP OF SECURITIES

Feb 18, 2026

4.7 KB

Feb 20, 2026

0002064832-26-000051STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP OF SECURITIES

Feb 18, 2026

4.8 KB

Feb 20, 2026

0002064832-26-000050STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP OF SECURITIES

Feb 18, 2026

4.8 KB

25 filings shown

Filed	Form	Description
5/12/25	DEF 14A	DEF 14A	→
4/29/25	PRE 14A	PRE 14A	→
4/29/24	DEF 14A	DEF 14A	→
5/1/23	DEF 14A	DEF 14A	→
5/10/22	DEF 14A	DEF 14A	→
4/29/22	PRE 14A	PRE 14A	→
↓

Filed	Form	Description
2/17/26	SCHEDULE 13G/A	SCHEDULE 13G/A	→
2/12/26	SCHEDULE 13G/A	SCHEDULE 13G/A	→
12/16/25	144	144	→
11/25/25	144	144	→
11/24/25	144	144	→
11/3/25	SCHEDULE 13D/A	SCHEDULE 13D/A	→
↓

Organogenesis Holdings Inc.

Financials

Earnings Releases (8-K)

News (8-K)

Prospectuses & Registrations

Filing History(659 filings)

Proxies

Ownership

Other Filings

Filed	Form	Description
3/3/26	4	STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP OF SECURITIES	→
3/3/26	4/A	AMENDED STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP OF SECURITIES	→
3/3/26	4/A	AMENDED STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP OF SECURITIES	→
3/3/26	4/A	AMENDED STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP OF SECURITIES	→
3/3/26	4/A	AMENDED STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP OF SECURITIES	→
3/3/26	4/A	AMENDED STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP OF SECURITIES	→
↓